Lacosamide
NDC 50268-492, Lacosamide, tablet, from AvPAK.
- Product NDC
- 50268-492
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208308
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/50268-492 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE100 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-492-10 | 50268049210 | 100 BLISTER PACK in 1 BOX (50268-492-10) / 1 TABLET in 1 BLISTER PACK (50268-492-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/5ca5b043-533e-2d1a-e063-6294a90a8d4a
Use it
Look up 50268-492 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-492 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-492. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.